IMMP
IMMUTEP Ltd
NASDAQ · Healthcare · Biotechnology · AU
$0.29
−9.21%Next report
Analyst consensus
- Next report date
- Feb 25, 2027
- EPS estimate
- -$0.06
- Revenue estimate
- $1.9M
Latest reported
- Last report date
- Aug 30, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.03
- Revenue actual
- $9.9M
- Revenue estimate
- $11.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -128.3%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 30, 2026 | -$0.03 | -$0.17 | Miss -548.99% | $9.9M |
| Feb 24, 2026 | -$0.14 | -$0.15 | Miss -9.04% | $3.9M |
| Aug 28, 2025 | -$0.12 | -$0.18 | Miss -44.02% | $1.2M |
| Feb 26, 2025 | -$0.08 | -$0.01 | Beat 88.73% | $1.9M |
| Aug 30, 2024 | -$0.08 | -$0.01 | Beat 86.12% | $1.2M |
| Feb 24, 2023 | -$0.08 | -$0.02 | Beat 80.82% | $1.2M |
| Jul 27, 2022 | — | -$0.01 | — | $702.8K |
| Feb 22, 2022 | -$0.23 | -$0.01 | Beat 94.03% | $1.5M |
| Aug 30, 2021 | -$0.38 | -$0.01 | Beat 97.41% | $1.2M |
| Feb 23, 2021 | -$0.36 | -$0.38 | Miss -5.56% | $1.7M |
| Aug 25, 2020 | — | -$0.01 | — | $1.2M |
| Feb 24, 2020 | -$0.19 | -$0.01 | Beat 94.41% | $5.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 25, 2027